Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy - a prospective cohort study.
Susanne Irene ScottAnne Kathrine Østergaard MadsenNiclas RubekHenrik KehletChristian von BuchwaldPublished in: Acta oto-laryngologica (2020)
DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH30, which remained high in DAOH180, while patients treated with RT with reduced DAOH30, had reduced DAOH180 calling for further large-scale studies.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- early stage
- papillary thyroid
- peritoneal dialysis
- locally advanced
- adverse drug
- radiation therapy
- acute care
- emergency department
- radiation induced
- young adults
- lymph node metastasis
- patient reported outcomes
- case control